1
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled release formulations coated with aqueous dispersions of acrylic polymers. Euro Celtique, Steinberg Raskin & Davidson P C, June 17, 1997: US05639476 (615 worldwide citation)

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin ...


2
Ivan A Korolkov, Viktor S Saveliev, Evgeny G Yablokov, Georgy V Astafiev, Viktor V Tishin, Boris A Smirnov: Surgical suturing instrument for application of a staple suture. Steinberg & Raskin, December 15, 1981: US04305539 (339 worldwide citation)

Disclosure is made of a surgical instrument, comprising a supporting body with a replaceable die, a magazine with staples, a carriage-holder, a staple ejector, a carriage-holder mechanical actuator, and a staple ejector mechanical actuator.


3
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtigue, Steinberg Raskin & Davidson, April 16, 1996: US05508042 (300 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


4
Benjamin Oshlack, John J Minogue, Mark Chasin: Controlled release oxycodone compositions. Euroceltique, Steinberg & Raskin, November 30, 1993: US05266331 (282 worldwide citation)

A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer (pH between 1.6 ...


5
Benjamin Oshlack, Frank Pedi Jr, Mark Chasin: Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer. Euroceltigue, Steinberg & Raskin, December 28, 1993: US05273760 (279 worldwide citation)

A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active agent with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature a ...


6
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Stabilized controlled release formulations having acrylic polymer coating. Euroceltique, Steinberg & Raskin, February 15, 1994: US05286493 (278 worldwide citation)

A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of an acrylic polymer is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of the plasticized acrylic polymer and then curing the coated substrate at ...


7
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled-release formulations coated with aqueous dispersions of ethylcellulose. Euroceltique, Steinberg Raskin & Davidson, December 5, 1995: US05472712 (270 worldwide citation)

A stabilized solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic polymer is obtained by overcoating a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic ...


8
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 27, 1996: US05549912 (270 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


9
Richard Sackler, Paul Goldenheim, Robert Kaiko: Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level. Euroceltique, Steinberg Raskin & Davidson, December 26, 1995: US05478577 (261 worldwide citation)

Patients are treated with 24-hour oral sustained release opioid formulations which upon administration quickly release an effective portion of the opioid contained therein such that there is an initially more rapid opioid release so that the minimum effective analgesic concentration of the opioid ca ...


10
Benjamin Oshlack, Mark Chasin, John Joseph Minogue, Robert Francis Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 12, 1997: US05656295 (258 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...